These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 38751790)

  • 1. Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review.
    Zhang Q; Xia Y; Wang F; Yang D; Liang Z
    Front Pharmacol; 2024; 15():1385565. PubMed ID: 38751790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting ferroptosis regulators by natural products in colorectal cancer.
    Zhang Y; Xie J
    Front Pharmacol; 2024; 15():1374722. PubMed ID: 38860170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducing ferroptosis by traditional medicines: a novel approach to reverse chemoresistance in lung cancer.
    Wang Y; Hu J; Fleishman JS; Li Y; Ren Z; Wang J; Feng Y; Chen J; Wang H
    Front Pharmacol; 2024; 15():1290183. PubMed ID: 38855750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of Ferroptosis in Non-small Cell Lung Cancer and Progress 
of Traditional Chinese Medicine Intervention].
    Guo X; Wang T; Xia J; Zeng H; Shi W
    Zhongguo Fei Ai Za Zhi; 2024 Mar; 27(3):216-230. PubMed ID: 38590196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCL1 inhibition: a promising approach to augment the efficacy of sorafenib in NSCLC through ferroptosis induction.
    Huang CY; Chen LJ; Chen CS; Wang CY; Hong SY
    Cell Death Discov; 2024 Mar; 10(1):137. PubMed ID: 38485916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy.
    Xing N; Du Q; Guo S; Xiang G; Zhang Y; Meng X; Xiang L; Wang S
    Cell Death Discov; 2023 Apr; 9(1):110. PubMed ID: 37005430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients.
    Zhang N; Wu Y; Wu Y; Wang L; Chen J; Wang X; Chard Dunmall LS; Cheng Z; Wang Y
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-3'-hydroxy-7', 2', 4'-trimethoxyisoxane, a novel ferroptosis inducer, promotes NSCLC cell death through inhibiting Nrf2/HO-1 signaling pathway.
    Chen J; Zhou S; Zhang X; Zhao H
    Front Pharmacol; 2022; 13():973611. PubMed ID: 36105203
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting ferroptosis regulators in lung cancer: Exploring natural products.
    Yuhao W; Shenghua C; Jueying C; Shate X; Rongrong S; Xiangfeng S
    Heliyon; 2024 Jul; 10(14):e33934. PubMed ID: 39104501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis in Non-Small Cell Lung Cancer: Progression and Therapeutic Potential on It.
    Zou J; Wang L; Tang H; Liu X; Peng F; Peng C
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel quinoline derivative, DFIQ, sensitizes NSCLC cells to ferroptosis by promoting oxidative stress accompanied by autophagic dysfunction and mitochondrial damage.
    Bow YD; Ko CC; Chang WT; Chou SY; Hung CT; Huang JL; Tseng CH; Chen YL; Li RN; Chiu CC
    Cancer Cell Int; 2023 Aug; 23(1):171. PubMed ID: 37587444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trabectedin induces ferroptosis via regulation of HIF-1α/IRP1/TFR1 and Keap1/Nrf2/GPX4 axis in non-small cell lung cancer cells.
    Cai S; Ding Z; Liu X; Zeng J
    Chem Biol Interact; 2023 Jan; 369():110262. PubMed ID: 36396105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis.
    Yu J; Zhong B; Zhao L; Hou Y; Ai N; Lu JJ; Ge W; Chen X
    Drug Resist Updat; 2023 Sep; 70():100977. PubMed ID: 37321064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sanguinarine Represses the Growth and Metastasis of Non-small Cell Lung Cancer by Facilitating Ferroptosis.
    Xu R; Wu J; Luo Y; Wang Y; Tian J; Teng W; Zhang B; Fang Z; Li Y
    Curr Pharm Des; 2022; 28(9):760-768. PubMed ID: 35176976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-treatment of betulin and gefitinib is effective against EGFR wild-type/KRAS-mutant non-small cell lung cancer by inducing ferroptosis.
    Yan WY; Cai J; Wang JN; Gong YS; Ding XB
    Neoplasma; 2022 May; 69(3):648-656. PubMed ID: 35330996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction.
    Jiaqi L; Siqing H; Qin W; di Z; Bei Z; Jialin Y
    Phytomedicine; 2023 Jan; 109():154601. PubMed ID: 36610134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-27a-3p Promotes Non-Small Cell Lung Cancer Through SLC7A11-Mediated-Ferroptosis.
    Lu X; Kang N; Ling X; Pan M; Du W; Gao S
    Front Oncol; 2021; 11():759346. PubMed ID: 34722314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM11 promotes cell proliferation of non-small cell lung cancer through the inhibition of ferroptosis by AMPK.
    Liang Z; Li J; Zhang G; Chen M
    Clin Respir J; 2023 Oct; 17(10):1006-1016. PubMed ID: 37604203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin Derivatives Inhibit Non-small Cell Lung Cancer Cells Through Induction of ROS-dependent Apoptosis/Ferroptosis.
    Zhang Q; Yi H; Yao H; Lu L; He G; Wu M; Zheng C; Li Y; Chen S; Li L; Yu H; Li G; Tao X; Fu S; Deng X
    J Cancer; 2021; 12(13):4075-4085. PubMed ID: 34093811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scoparone induces both apoptosis and ferroptosis via multiple mechanisms in non-small-cell lung cancer cells.
    Shen H; Wei Y; Yang Q; Cai Y; Zhu K; Chen X
    Toxicol In Vitro; 2023 Sep; 91():105627. PubMed ID: 37315743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.